Manufacturer record
Salus Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
15 batches manufactured by Salus Pharmaceuticals (Himachal Pradesh) were declared Not of Standard Quality between February 2019 and August 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SPT260796B, Calcium & Vitamin D3 Tablets IP (AVCAL D3) (exp Mar 2028). DTL, Jaipur (state lab) found it not of standard quality: The sample does not conforms to the IP with respect to Assay of Vitamin D3. Listed in the August 2026 alert.
Records by type
15 records linked to Salus Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium & Vitamin D3 Tablets IP (AVCAL D3) | Batch SPT260796BMfg Apr 2026 · Exp Mar 2028 | The sample does not conforms to the IP with respect to Assay of Vitamin D3Assay | DTL, JaipurState lab | Aug 2026 |
| Ondansetron Orally Disntagrating Tablets IP | Batch SPT252281Mfg Oct 2025 · Exp Sep 2027 | The sample has been declared as NSQ as it does not conform to IP standard with respect to Test for DisintegrationDisintegration | RDTL. Bellary KarnatakaState lab | Jul 2026 |
| Methotrexate Tablets IP 2.5mg | Batch SPOT260026BMfg Feb 2026 · Exp Jan 2028 | MisbrandedMisbranded | Andmand NicobarState lab | Jun 2026 |
| Albendazole Tablets IP 400 mg. (Macbi-400) | Batch SPT241854Mfg Sep 2024 · Exp Aug 2026 | Dissolution of AlbendazoleDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Amlodipine Besylate Tablets I.P. 2.5 mg (AMLODOSE ? 2.5) | Batch SPT240321Mfg Feb 2024 · Exp Jan 2026 | The Sample does not conform to standard in respect of the test for Assay & Uniformity of ContentAssay | State Drugs Testing Laboratory, Agartala, TripuraState lab | May 2025 |
| GLIMEPIRIDE TABLETS IP (GLIMP-1) | Batch SPT240261Mfg Feb 2024 · Exp Jan 2026 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Dec 2024 |
| OMEPRAZOLE & DOMPERIDONE CAPSULES (REMIZOLE-D) | Batch SPC230578 CMfg Mar 2023 · Exp Feb 2025 | THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).Dissolution | State Lab MaharashtraState lab | Jun 2024 |
| Zinc Sulphate Tablets IP. (Saluzinc- 20) | Batch SPT230376Mfg Feb 2023 · Exp Jan 2025 | DisintegrationDisintegration | RDTL GuwahatiState lab | Mar 2024 |
| SPIRONOLACTONE TABLETS IP (SPIRNORAV-100) | Batch SPT221635Mfg Jul 2022 · Exp Jun 2024 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2023 |
| Clorin Capsules (Aspirin & Clopidogrel Capsules) | Batch SPC221847Mfg Aug 2022 · Exp Jul 2024 | Assay of Aspirin & Dissolution of AspirinAssay | CDL KolkataCDSCO lab | Jun 2023 |
| Astrizo-2.5 Tablets (Letrozole Tablets I.P. 2.5 mg) | Batch SPT220701Mfg Mar 2022 · Exp Feb 2024 | DissolutionDissolution | CDL KolkataCDSCO lab | Apr 2023 |
| Cantop-40 Tablets (Pantoprazole Tablets IP) | Batch SPT170513DMfg Apr 2022 · Exp Sep 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2022 |
| Fexofenadine Hydrochloride Tablets IP 180 mg (Medrofex-180 Tablets) | Batch SPT190012AMfg Jan 2019 · Exp Dec 2020 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Dec 2019 |
| Medtoin (Phenytoin Sodium Tablets I.P.) | Batch SPT190048AMfg Jan 2019 · Exp Dec 2020 | Description and DisintegrationDescription | CDL KolkataCDSCO lab | Nov 2019 |
| Cefixime & Lactic Acid Bacillus Tablets (Tixi-200 LB) | Batch FSP17159AMfg Oct 2017 · Exp Sep 2019 | Uniformity of WeightUniformity of weight/content | Drugs Control Department, MizoramCDSCO lab | Feb 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.